Startseite

Hydrocortisone Succinate

Hydrocortisone Succinate

Spezifikationen

2203-97-6CAS-Nummer
218-612-3EG-Nummer
4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acidIUPAC-Name
C25H34O8Chemische Formel
462.5 g/molMolekulargewicht
2203-97-6; Hydrocortisone succinate; Cortisol succinate; Hydrocortisone hydrogen succinate; Hydrocortisone hemisuccinate anhydrous; NSC-7576; ORISTAR HCSHS; Hydroxycortisone succinate; IHV1VP592V; CHEBI:31677; Cortisol 21-(hydrogen succinate); 11beta,17alpha,21-trihydroxypregn-4-ene-3,20-dione 21-succinate; 11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 21-(hydrogensuccinate); RefChem:789013; 11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 21-(hydrogen succinate); pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, (11beta)-; 218-612-3; Hydrocortisone 21-hemisuccinate; Cortisol 21-hemisuccinate; Pregn-4-ene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, (11b)-; MLS000028530; MLS001146928; Hydrocortisone succinate [JAN]; Solucortef; Arcocort; Intracort; Oralsone; Corlan; MFCD00046256; 4-(2-((8S,9S,10R,11S,13S,14S,17R)-11,17-Dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoic acid; Emi-Corlin; Solu-Hizon; SMR000058328; ST075193; EF-Cortelan soluble; 4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-ethoxy]-4-oxo-butanoic acid; 4-[2-[(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid; Aacicortisol; Aftasome; Oralsome; Saxizon; C25H34O8; 3-{[2-((1S,10S,11S,15S,17S,2R,14R)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyc lo[8.7.0.0<2,7>.0<11,15>]heptadec-6-en-14-yl)-2-oxoethyl]oxycarbonyl}propanoic acid; Hydrocortisone Roussel; Hydrocortisone Leurquin; NCGC00022248-03; Cortisol, hydrogen succinate; Hydrocortisone 21-succinate; Hydrocortisonum Hemisuccinatum; Cortisol, 21-(hydrogen succinate); EINECS 218-612-3; Hydrocortisone 21-(hydrogen succinate); Opera_ID_1732; hydrocortisone-hemisuccinate; CHEMBL977; UNII-IHV1VP592V; SCHEMBL7664; Lopac0_000623; MLS002207249; Hydrokortison-21-Hemisuccinat; 4-((11,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl)oxy)-4-oxobutanoic acid; HY-B1402R; Hydrocortisone succinate (JP17); DTXSID40872905; Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, (11.beta.)-; VWQWXZAWFPZJDA-CGVGKPPMSA-N; HMS2235G13; HMS3259A14; HY-B1402; BDBM50016931; EBC-27158; Hydrocortisone hydrogen succinate CRS; LMST02030126; MSK011024; s5972; AKOS015969742; AC-6828; DB14545; FH44457; GS-6198; Hydrocortisone hemisuccinate (Standard); MSK011024-100A; NC00567; ST 25:5;O8; (11-beta)-21-(3-Carboxy-1-oxopropoxy)-11,17-dihydroxypreg-4-ene-3,20-dione; Preg-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, (11-beta)-; 4-{2-[(1R,3aS,3bS,9aR,9bS,10S,11aS)-1,10-dihydroxy-9a,11a-dimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-oxoethoxy}-4-oxobutanoic acid; SY122256; CS-0013125; NS00015393; EN300-55845; D01442; F826901; HYDROCORTISONE HYDROGEN SUCCINATE [WHO-DD]; Hydrocortisone 21-hemisuccinate, analytical standard; Q27104202; HYDROCORTISONE HYDROGEN SUCCINATE [EP MONOGRAPH]; Hydrocortisone hemisuccinate Solution in Acetonitrile, 100ug/mL; Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11, 17-dihydroxy-; 4-[(11beta,17-Dihydroxy-3,20-dioxopregn-4-en-21-yl)oxy]-4-oxobutanoic acid; Hydrocortisone hydrogen succinate, British Pharmacopoeia (BP) Reference Standard; Hydrocortisone hydrogen succinate, European Pharmacopoeia (EP) Reference Standard; 4-{2-[(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl]-2-oxoethoxy}-4-oxobutanoic acidSynonyme